Search Results - Anna Marra
- Showing 1 - 3 results of 3
-
1
The Impact of GLP-1 RAs and DPP-4is on Hospitalisation and Mortality in the COVID-19 Era: A Two-Year Observational Study by Salvatore Greco, Vincenzo M. Monda, Giorgia Valpiani, Nicola Napoli, Carlo Crespini, Fabio Pieraccini, Anna Marra, Angelina Passaro
Published in Biomedicines (2023-08-01)Get full text
Article -
2
Clinical, organizational, and pharmacoeconomic perspectives of dalbavancin vs standard of care in the infectious disease network by Daniela Segala, Marco Barbieri, Mariachiara Di Nuzzo, Melissa Benazzi, Aurora Bonazza, Letizia Romanini, Brunella Quarta, Kristian Scolz, Anna Marra, Diana Campioni, Rosario Cultrera
Published in Global & Regional Health Technology Assessment (2024-07-01)Get full text
Article -
3
Italian Emergency Department Visits and Hospitalizations for Outpatients’ Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study) by Niccolò Lombardi, Giada Crescioli, Alessandra Bettiol, Marco Tuccori, Marco Tuccori, Annalisa Capuano, Roberto Bonaiuti, Alessandro Mugelli, Mauro Venegoni, Giuseppe Danilo Vighi, Alfredo Vannacci, Alfredo Vannacci, the MEREAFaPS Study group, Maria Luisa Aiezza, Alessandra Bettiol, Daria Bettoni, Corrado Blandizzi, Roberto Bonaiuti, Valentina Borsi, Annalisa Capuano, Errica Cecchi, Irma Convertino, Giada Crescioli, Martina Del Lungo, Cristina Di Mauro, Gabriella Farina, Sara Ferraro, Annamaria Fucile, Elena Galfrascoli, Elisabetta Geninatti, Linda Giovannetti, Luca Leonardi, Rosa Liccardo, Niccolò Lombardi, Anna Marra, Eleonora Marrazzo, Giovanna Monina, Alessandro Mugelli, Silvia Pagani, Maria Parrilli, Concetta Rafaniello, Francesco Rossi, Marco Rossi, Stefania Rostan, Marco Ruocco, Marita Sironi, Giulia Spada, Liberata Sportiello, Marco Tuccori, Alfredo Vannacci, Mauro Venegoni, Giuditta Violetta Vighi, Giuseppe Danilo Vighi
Published in Frontiers in Pharmacology (2020-04-01)Get full text
Article